TGN News

When we set up The Genotype Network in November 2022, we had a few goals in mind. Of course — building an international community of like-minded Life Sciences Regulatory lawyers who love to collaborate with M&A colleagues on cross-border transactions. That vision was always at the heart of it. But we also had a more tangible ambition: to become a headline sponsor of the IBA M&A Conference — the premier M&A lawyers event in the world, held every June in New York City. This yea

Mateusz Mądry, DZP, Poland

Andrew Bochner, Bochner Law in New York, USA

Louise Bertelsen-Forman from Bech-Bruun, Denmark We are pleased to announce that The Genotype Network has expanded with Denmark! Louise Bertelsen Forman is the Life Sciences Regulatory lawyer of Bech-Bruun - a top-tier, full-service Danish law firm and one of the largest in Denmark . We are delighted to have her join the network! Welcome, Louise!

Takuya Mima From Tokyo International Law Office (TKI) We are pleased to announce that Takuya Mima from Tokyo International Law Office (TKI) has joined as the newest member of The Genotype Network in Japan 🇯🇵 As the world's third-largest pharmaceutical market and a global leader in medical device innovation and regulatory science, Japan plays a crucial role in the international Life Sciences industry, making it an essential hub for companies seeking to advance healthcare sol

We are delighted to welcome Andrea Tithecott from #AlTamimi as the newest United Arab Emirates (UAE) member of @TheGenotypeNetwork! Andrea Tithecott is a Partner in the Regulatory practice in Abu Dhabi & Dubai, she heads the Al Tamimi & Company’s Healthcare group. Andrea Tithecott, Al Tamimi & Co Her membership significantly strengthens our footprint in the UAE. She works regularly on public-private partnership projects, Governance Framework and Regulatory blueprints, Regul

We are delighted to welcome Dara Jospe from Fas We are delighted to welcome Dara Jospe from Fasken as the newest Canadian member of The Genotype Network! Her membership significantly strengthens our footprint in Canada, a critical market in the life sciences sector. Dara was a speaker during the TGN Conference last September and she was quoted in the M&A article, find the translation here: https://lnkd.in/ePkFRzar (TGN News of 30 October 2025) Dara is known for develop

Dutch version: https://mena.nl/artikel/hanneke-later-nijland-genome-lawyers-farmadeals-regulatory-due-diligence/ By: Jan Bletz 29 October 2025 In the heavily regulated pharma market, buyers face greater risks. Regulatory due diligence offers a solution. · Geopolitical shifts increase risks in the pharma sector: The US is closing itself off and implementing protectionist measures, China is developing into an innovative biotech power, and Europe remains fragmented with

We are pleased to welcome a new member to our network: Annemarie Lagger from Walder Wyss! Annemarie has extensive experience in the pharmaceutical and biotech sectors. Her knowledge and expertise are a valuable addition to our group, and we are particularly glad to strengthen our presence in Switzerland — a key jurisdiction in the life sciences industry. Please see: www.thegenotypenetwork.com for more information about the network

Join us on September 26th in Amsterdam for The Genotype Network (TGN) conference in Amsterdam. We'll delve into "The impact of...

The Genotype Network (TGN) welcomes the renowned Elizabethann Wright as our new Belgian Member. Elizabethan has a wealth of experience and is a familiar face to many of us. Ne w TGN Member for Belgium: Elizabethan Wright Elizabethann has been practicing in the life sciences sector for almost 40 years in private practice and international institutions. Elisabethann supports clients through the procedures and regulations necessary to place and keep their products on the Europea

Strengthening Global M&A Support in Life Sciences The Genotype Network ( TGN ) is a global alliance of leading Life Sciences Regulatory...

Interview with the founder of TGN Hanneke Later-Nijland explains about the importance of a collaboration between regulatory lawyers and...

A recently published article on Law.com takes an interesting approach as to the role of regulatory lawyers in M&A transactions.

A case that could possibly have been avoided or mitigated if regulatory professionals had been called in time.

We are delighted to welcome you to Amsterdam for our first ever The Genotype Network (TGN) network event.